Genetic Susceptibility to Kidney Cancer

Baylor College of Medicine

Status: Terminated

Conditions: Renal Cell Carcinoma

Study type: Observational

Funder types: Other

Identifiers

NCT00854022

H-17150

Details and patient eligibility

About

This study will further the understanding of the genetic events leading to the development of RCC.

Full description

This study will further the understanding of the genetic events leading to the development of RCC; explore the genetic basis for genetic instability and how it affects cancer risk; and eventually provide a means of identifying a subgroup of individuals who are most likely to develop RCC. Such individuals may then be targeted for intervention programs such as chemoprevention or dietary modification.

Enrollment: 6 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients of any ethnicity or sex, who have a been diagnosed with possible Renal Cell Carcinoma within the past year.

Exclusion criteria

• Must not have received chemotherapy, biological therapy or radiation therapy in the 6 months preceding enrollment will
• Must not have had RCC, or metastatic RCC,
• Must not have had a renal transplantation

Trial design

6 participants in 2 patient groups

Healthy

Description:

Healthy adults, of any ethnicity, or sex, and with no previous history of cancer, except for non-melanoma skin cancer

RCC

Description:

Adult patients with newly diagnosed (diagnosed within the year of enrollment) renal carcinoma (RCC) any ethnicity, or sex, who have not received prior chemotherapy or radiotherapy.